{"date":"2025-09-01","count":20,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6885-2025-09-01-1922-l2vmgg","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2025-09-01","time":"19:22:25","subject":"公告本公司114年9月2日受邀參加元富證券舉辦之法人說明會，說明公司營運概況及未來展望。","clause":"第12款","fact_date":"2025-09-02","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2025-09-01 19:22，「公告本公司114年9月2日受邀參加元富證券舉辦之法人說明會，說明公司營運概況及未來展望。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6885-2025-09-01-1917-91ylju","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2025-09-01","time":"19:17:54","subject":"公告本公司臨時董事會通過重要決議","clause":"第51款","fact_date":"2025-09-01","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2025-09-01 19:17，「公告本公司臨時董事會通過重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2025-09-01-1829-g3q1ph","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-09-01","time":"18:29:05","subject":"(更正114年08月19日公告)公告本公司董事會通過取得望德斯國際股份有限公司30%股權案","clause":"第17款","fact_date":"2025-08-19","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-09-01 18:29，「(更正114年08月19日公告)公告本公司董事會通過取得望德斯國際股份有限公司30%股權案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2025-09-01-1822-1joy3nv","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-09-01","time":"18:22:30","subject":"更正私募專區-董事會決議日起兩日內應申報相關資訊","clause":"第44款","fact_date":"2025-09-01","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-09-01 18:22，「更正私募專區-董事會決議日起兩日內應申報相關資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-09-01-1738-1ttvy79","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-09-01","time":"17:38:50","subject":"公告本公司114年第一次股東臨時會通過解除新選任董事及法人董事新任代表人之競業禁止限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-09-01 17:38，「公告本公司114年第一次股東臨時會通過解除新選任董事及法人董事新任代表人之競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-09-01-1737-5fm9or","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-09-01","time":"17:37:51","subject":"公告本公司114年第一次股東臨時會補選1席、增額1席獨立董事案，共兩席之當選名單。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-09-01 17:37，「公告本公司114年第一次股東臨時會補選1席、增額1席獨立董事案，共兩席之當選名單。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2025-09-01-1705-hqko0z","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2025-09-01","time":"17:05:27","subject":"代子公司APBIO PTY LTD公告研發中雙特異性抗體抗癌新藥AP601，獲得澳洲人體試驗倫理委員會同意進行第一期人體臨床試驗","clause":"第44款","fact_date":"2025-09-01","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2025-09-01 17:05，「代子公司APBIO PTY LTD公告研發中雙特異性抗體抗癌新藥AP601，獲得澳洲人體試驗倫理委員會同意進行第一期人體」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-09-01-1649-12aw4j4","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-09-01","time":"16:49:51","subject":"代重要子公司意能生技(股)公司公告董事會決議召開114年第二次普通股暨特別股股東臨時會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-09-01 16:49，「代重要子公司意能生技(股)公司公告董事會決議召開114年第二次普通股暨特別股股東臨時會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-09-01-1646-1n5osjp","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-09-01","time":"16:46:44","subject":"代重要子公司Alvogen Korea Co., Ltd.公告董事當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-09-01 16:46，「代重要子公司Alvogen Korea Co., Ltd.公告董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-09-01-1645-3crnbg","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-09-01","time":"16:45:51","subject":"代重要子公司Alvogen Korea Co., Ltd.公告2025年股東臨時會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-09-01 16:45，「代重要子公司Alvogen Korea Co., Ltd.公告2025年股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-09-01-1644-4b8igh","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-09-01","time":"16:44:51","subject":"代重要子公司Alvogen Korea Co., Ltd.公告召開2025年股東臨時會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-09-01 16:44，「代重要子公司Alvogen Korea Co., Ltd.公告召開2025年股東臨時會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-09-01-1641-1xrs60h","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-09-01","time":"16:41:10","subject":"代重要子公司意能生技股份有限公司公告董事會決議辦理現金增資發行新股事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-09-01 16:41，「代重要子公司意能生技股份有限公司公告董事會決議辦理現金增資發行新股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-09-01-1620-13anmf3","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-09-01","time":"16:20:57","subject":"公告本公司國內第三次無擔保轉換公司債到期還本暨終止上櫃事宜","clause":"第51款","fact_date":"2025-09-01","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-09-01 16:20，「公告本公司國內第三次無擔保轉換公司債到期還本暨終止上櫃事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-09-01-1609-11poh1f","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-09-01","time":"16:09:38","subject":"公告本公司董事會決議現金增資發行普通股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-09-01 16:09，「公告本公司董事會決議現金增資發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-09-01-1539-1k2eyhy","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-09-01","time":"15:39:18","subject":"公告本公司董事會決議辦理減資彌補虧損召開重大訊息記者會內容","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-09-01 15:39，「公告本公司董事會決議辦理減資彌補虧損召開重大訊息記者會內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-09-01-1538-587n2p","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-09-01","time":"15:38:56","subject":"公告本公司董事會決議召開民國114年第一次股東臨時會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-09-01 15:38，「公告本公司董事會決議召開民國114年第一次股東臨時會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-09-01-1538-1nxkmx0","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-09-01","time":"15:38:31","subject":"公告本公司董事會決議辦理減資彌補虧損","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-09-01 15:38，「公告本公司董事會決議辦理減資彌補虧損」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2025-09-01-1519-16u2prg","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2025-09-01","time":"15:19:05","subject":"代子公司公告「COMPOSITION AND METHOD FOR TREATINGA DRUG-RESISTANT CANCER用於治療抗藥性癌症的組合物和方法」取得澳洲發明專利","clause":"第44款","fact_date":"2025-09-01","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2025-09-01 15:19，「代子公司公告「COMPOSITION AND METHOD FOR TREATINGA DRUG-RESISTANT C」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2025-09-01-1508-785q6r","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2025-09-01","time":"15:08:48","subject":"公告本公司董事長訂定民國114年第二季除息基準日等相關事宜","clause":"第14款","fact_date":"2025-09-01","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2025-09-01 15:08，「公告本公司董事長訂定民國114年第二季除息基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-09-01-1345-q203yi","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-09-01","time":"13:45:41","subject":"公告本公司重要營運主管異動案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-09-01 13:45，「公告本公司重要營運主管異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}